Rare diseases
Investigational molecules
Locations
Les Cauquillous, 81500, France
Research activity includes locally advanced and metastatic non-small cell lung cancer, with interest in tumors driven by EGFR tyrosine kinase inhibitor resistance as well as cancers carrying BRAF and/or NRAS mutations.
The portfolio also covers investigational oral anticancer agents for molecularly defined cancer subgroups.
Pierre Fabre Medicament runs clinical trials in conditions such as Non-small cell lung cancer metastatic, Epstein-Barr virus associated lymphoproliferative disorder, Neoplasm, Post transplant lymphoproliferative disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumFrance
AustriaAustriaFrance
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
